Literature DB >> 25035214

Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution.

Susannah G Ellsworth1, Sara R Alcorn2, Russell K Hales1, Todd R McNutt1, Theodore L DeWeese1, Thomas J Smith3.   

Abstract

PURPOSE: This study evaluates outcomes and patterns of care among patients receiving radiation therapy (RT) for bone metastases at a high-volume academic institution. METHODS AND MATERIALS: Records of all patients whose final RT course was for bone metastases from April 2007 to July 2012 were identified from electronic medical records. Chart review yielded demographic and clinical data. Rates of complicated versus uncomplicated bone metastases were not analyzed.
RESULTS: We identified 339 patients whose final RT course was for bone metastases. Of these, 52.2% were male; median age was 65 years old. The most common primary was non-small-cell lung cancer (29%). Most patients (83%) were prescribed ≤10 fractions; 8% received single-fraction RT. Most patients (52%) had a documented goals of care (GOC) discussion with their radiation oncologist; hospice referral rates were higher when patients had such discussions (66% with vs 50% without GOC discussion, P=.004). Median life expectancy after RT was 96 days. Median survival after RT was shorter based on inpatient as opposed to outpatient status at the time of consultation (35 vs 136 days, respectively, P<.001). Hospice referrals occurred for 56% of patients, with a median interval between completion of RT and hospice referral of 29 days and a median hospice stay of 22 days.
CONCLUSIONS: These data document excellent adherence to American Society for Radiation Oncolology Choosing Wisely recommendation to avoid routinely using >10 fractions of palliative RT for bone metastasis. Nonetheless, single-fraction RT remains relatively uncommon. Participating in GOC discussions with a radiation oncologist is associated with higher rates of hospice referral. Inpatient status at consultation is associated with short survival.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25035214      PMCID: PMC4332799          DOI: 10.1016/j.ijrobp.2014.04.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial.

Authors:  James A Tulsky; Robert M Arnold; Stewart C Alexander; Maren K Olsen; Amy S Jeffreys; Keri L Rodriguez; Celette Sugg Skinner; David Farrell; Amy P Abernethy; Kathryn I Pollak
Journal:  Ann Intern Med       Date:  2011-11-01       Impact factor: 25.391

2.  Five things physicians and patients should question in hospice and palliative medicine.

Authors:  Daniel Fischberg; Janet Bull; David Casarett; Laura C Hanson; Scott M Klein; Joseph Rotella; Thomas Smith; C Porter Storey; Joan M Teno; Eric Widera
Journal:  J Pain Symptom Manage       Date:  2013-02-22       Impact factor: 3.612

3.  Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.

Authors:  B Ashleigh Guadagnolo; Kai-Ping Liao; Linda Elting; Sharon Giordano; Thomas A Buchholz; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

4.  Talking with patients about dying.

Authors:  Thomas J Smith; Dan L Longo
Journal:  N Engl J Med       Date:  2013-01-31       Impact factor: 91.245

Review 5.  Closing the patient-oncologist communication gap: a review of historic and current efforts.

Authors:  A Khoa Pham; Marianne T Bauer; Stefan Balan
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

6.  Hospice enrollment saves money for Medicare and improves care quality across a number of different lengths-of-stay.

Authors:  Amy S Kelley; Partha Deb; Qingling Du; Melissa D Aldridge Carlson; R Sean Morrison
Journal:  Health Aff (Millwood)       Date:  2013-03       Impact factor: 6.301

7.  Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer.

Authors:  Aileen B Chen; Angel Cronin; Jane C Weeks; Elizabeth A Chrischilles; Jennifer Malin; James A Hayman; Deborah Schrag
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

8.  Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer.

Authors:  Justin E Bekelman; Andrew J Epstein; Ezekiel J Emanuel
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

9.  Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?

Authors:  Gabrielle B Rocque; Anne E Barnett; Lisa C Illig; Jens C Eickhoff; Howard H Bailey; Toby C Campbell; James A Stewart; James F Cleary
Journal:  J Oncol Pract       Date:  2013-01       Impact factor: 3.840

Review 10.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

View more
  14 in total

Review 1.  A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management.

Authors:  Hely Shah; Julian Surujballi; Arif Ali Awan; Brian Hutton; Angel Arnaout; Risa Shorr; Lisa Vandermeer; Mashari Jemaan Alzahrani; Mark Clemons
Journal:  Breast Cancer Res Treat       Date:  2020-11-06       Impact factor: 4.872

2.  End of life care for glioblastoma patients at a large academic cancer center.

Authors:  Kamini E Kuchinad; Roy Strowd; Anne Evans; W Anthony Riley; Thomas J Smith
Journal:  J Neurooncol       Date:  2017-05-20       Impact factor: 4.130

3.  Frequency of Complicated Symptomatic Bone Metastasis Over a Breadth of Operational Definitions.

Authors:  Sara R Alcorn; Christen R Elledge; Jean L Wright; Thomas J Smith; Todd R McNutt; Jacob Fiksel; Scott L Zeger; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-12-02       Impact factor: 7.038

4.  Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.

Authors:  Raj Satkunasivam; Andre E Kim; Mihir Desai; Mike M Nguyen; David I Quinn; Leslie Ballas; Juan Pablo Lewinger; Mariana C Stern; Ann S Hamilton; Monish Aron; Inderbir S Gill
Journal:  J Urol       Date:  2015-02-21       Impact factor: 7.450

Review 5.  Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.

Authors:  Jeffrey J Tosoian; Michael A Gorin; Ashley E Ross; Kenneth J Pienta; Phuoc T Tran; Edward M Schaeffer
Journal:  Nat Rev Urol       Date:  2016-10-11       Impact factor: 14.432

6.  30-Day Mortality Following Palliative Radiotherapy.

Authors:  Miriam Vázquez; Manuel Altabas; Diana C Moreno; Abraham A Geng; Santiago Pérez-Hoyos; Jordi Giralt
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

Review 7.  International patterns of practice in radiotherapy for bone metastases: A review of the literature.

Authors:  Rachel McDonald; Edward Chow; Henry Lam; Leigha Rowbottom; Hany Soliman
Journal:  J Bone Oncol       Date:  2014-11-07       Impact factor: 4.072

8.  Efficacy and Survival after Palliative Radiotherapy for Malignant Pulmonary Obstruction.

Authors:  Adam G Johnson; Michael H Soike; Michael K Farris; Ryan T Hughes
Journal:  J Palliat Med       Date:  2021-07-13       Impact factor: 2.947

9.  Influence of the treatment schedule on the physicians' decisions to refer bone metastases patients for palliative radiotherapy: a questionnaire survey of physicians in various specialties.

Authors:  Tetsuo Saito; Ryo Toya; Akiko Semba; Tomohiko Matsuyama; Natsuo Oya
Journal:  Nagoya J Med Sci       Date:  2016-08       Impact factor: 1.131

10.  Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy.

Authors:  Sebastian M Christ; Markus Schettle; Annina Seiler; Matthias Guckenberger; David Blum; Nicolaus Andratschke; Caroline Hertler
Journal:  Clin Transl Radiat Oncol       Date:  2021-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.